AXOGEN INC (AXGN) Stock Fundamental Analysis

USA • Nasdaq • NASDAQ:AXGN • US05463X1063

33.91 USD
-1.02 (-2.92%)
Last: Feb 9, 2026, 02:15 PM
Overview Stock Chart Technical Analysis Fundamental Analysis Analyst Ratings Earnings Estimates Financials Ownership News
Fundamental Rating

5

Overall AXGN gets a fundamental rating of 5 out of 10. We evaluated AXGN against 186 industry peers in the Health Care Equipment & Supplies industry. AXGN has an average financial health and profitability rating. AXGN is not valued too expensively and it also shows a decent growth rate.


Dividend Valuation Growth Profitability Health

4

1. Profitability

1.1 Basic Checks

  • AXGN had positive earnings in the past year.
  • In the past year AXGN had a positive cash flow from operations.
  • AXGN had negative earnings in each of the past 5 years.
  • In the past 5 years AXGN reported 4 times negative operating cash flow.
AXGN Yearly Net Income VS EBIT VS OCF VS FCFAXGN Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -10M -20M -30M -40M

1.2 Ratios

  • AXGN has a Return On Assets of -0.97%. This is in the better half of the industry: AXGN outperforms 72.58% of its industry peers.
  • With a decent Return On Equity value of -1.74%, AXGN is doing good in the industry, outperforming 72.58% of the companies in the same industry.
  • Looking at the Return On Invested Capital, with a value of 1.65%, AXGN is in the better half of the industry, outperforming 67.20% of the companies in the same industry.
Industry RankSector Rank
ROA -0.97%
ROE -1.74%
ROIC 1.65%
ROA(3y)-10.24%
ROA(5y)-11.1%
ROE(3y)-20.3%
ROE(5y)-20.84%
ROIC(3y)N/A
ROIC(5y)N/A
AXGN Yearly ROA, ROE, ROICAXGN Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 -20 -40 -60 -80

1.3 Margins

  • The Operating Margin of AXGN (1.84%) is better than 67.20% of its industry peers.
  • AXGN has a better Gross Margin (74.76%) than 84.95% of its industry peers.
  • In the last couple of years the Gross Margin of AXGN has remained more or less at the same level.
Industry RankSector Rank
OM 1.84%
PM (TTM) N/A
GM 74.76%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-1.72%
GM growth 5Y-1.5%
AXGN Yearly Profit, Operating, Gross MarginsAXGN Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 -20 40 60 80

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

6

2. Health

2.1 Basic Checks

  • AXGN has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
  • The number of shares outstanding for AXGN has been increased compared to 1 year ago.
  • AXGN has more shares outstanding than it did 5 years ago.
  • Compared to 1 year ago, AXGN has an improved debt to assets ratio.
AXGN Yearly Shares OutstandingAXGN Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M 40M
AXGN Yearly Total Debt VS Total AssetsAXGN Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M 200M

2.2 Solvency

  • An Altman-Z score of 9.74 indicates that AXGN is not in any danger for bankruptcy at the moment.
  • AXGN's Altman-Z score of 9.74 is amongst the best of the industry. AXGN outperforms 89.25% of its industry peers.
  • The Debt to FCF ratio of AXGN is 23.40, which is on the high side as it means it would take AXGN, 23.40 years of fcf income to pay off all of its debts.
  • AXGN has a better Debt to FCF ratio (23.40) than 68.82% of its industry peers.
  • A Debt/Equity ratio of 0.40 indicates that AXGN is not too dependend on debt financing.
  • With a Debt to Equity ratio value of 0.40, AXGN perfoms like the industry average, outperforming 46.77% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.4
Debt/FCF 23.4
Altman-Z 9.74
ROIC/WACC0.17
WACC9.98%
AXGN Yearly LT Debt VS Equity VS FCFAXGN Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50M 100M

2.3 Liquidity

  • A Current Ratio of 4.09 indicates that AXGN has no problem at all paying its short term obligations.
  • AXGN's Current ratio of 4.09 is fine compared to the rest of the industry. AXGN outperforms 69.35% of its industry peers.
  • A Quick Ratio of 2.64 indicates that AXGN has no problem at all paying its short term obligations.
  • With a decent Quick ratio value of 2.64, AXGN is doing good in the industry, outperforming 62.37% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 4.09
Quick Ratio 2.64
AXGN Yearly Current Assets VS Current LiabilitesAXGN Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

6

3. Growth

3.1 Past

  • AXGN shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 2089670227099910400.00%, which is quite impressive.
  • Looking at the last year, AXGN shows a quite strong growth in Revenue. The Revenue has grown by 18.72% in the last year.
  • Measured over the past years, AXGN shows a quite strong growth in Revenue. The Revenue has been growing by 11.92% on average per year.
EPS 1Y (TTM)2089670227099910400%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%71.43%
Revenue 1Y (TTM)18.72%
Revenue growth 3Y13.72%
Revenue growth 5Y11.92%
Sales Q2Q%23.51%

3.2 Future

  • AXGN is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 58.75% yearly.
  • Based on estimates for the next years, AXGN will show a quite strong growth in Revenue. The Revenue will grow by 17.07% on average per year.
EPS Next Y132.02%
EPS Next 2Y94.64%
EPS Next 3Y82.58%
EPS Next 5Y58.75%
Revenue Next Year20.14%
Revenue Next 2Y17.85%
Revenue Next 3Y17.64%
Revenue Next 5Y17.07%

3.3 Evolution

  • When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
AXGN Yearly Revenue VS EstimatesAXGN Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 200M 400M 600M
AXGN Yearly EPS VS EstimatesAXGN Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 0 0.5 -0.5 1 1.5

More info and screens

Find the best growth stocksShow best growing peers

4

4. Valuation

4.1 Price/Earnings Ratio

  • A Price/Earnings ratio of 116.93 indicates a quite expensive valuation of AXGN.
  • 66.13% of the companies in the same industry are more expensive than AXGN, based on the Price/Earnings ratio.
  • The average S&P500 Price/Earnings ratio is at 27.93. AXGN is valued rather expensively when compared to this.
  • AXGN is valuated quite expensively with a Price/Forward Earnings ratio of 68.85.
  • Based on the Price/Forward Earnings ratio, AXGN is valued a bit cheaper than the industry average as 66.67% of the companies are valued more expensively.
  • AXGN is valuated expensively when we compare the Price/Forward Earnings ratio to 27.77, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE 116.93
Fwd PE 68.85
AXGN Price Earnings VS Forward Price EarningsAXGN Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 20 40 60 80 100

4.2 Price Multiples

  • Based on the Enterprise Value to EBITDA ratio, AXGN is valued a bit cheaper than the industry average as 63.44% of the companies are valued more expensively.
  • Based on the Price/Free Cash Flow ratio, AXGN is valued a bit cheaper than 66.67% of the companies in the same industry.
Industry RankSector Rank
P/FCF 759.19
EV/EBITDA 161.15
AXGN Per share dataAXGN EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 1 2 3 4

4.3 Compensation for Growth

  • The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
  • AXGN's earnings are expected to grow with 82.58% in the coming years. This may justify a more expensive valuation.
PEG (NY)0.89
PEG (5Y)N/A
EPS Next 2Y94.64%
EPS Next 3Y82.58%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. Dividend

5.1 Amount

  • No dividends for AXGN!.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

AXOGEN INC

NASDAQ:AXGN (2/9/2026, 2:15:07 PM)

33.91

-1.02 (-2.92%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)10-29
Earnings (Next)03-03
Inst Owners91.28%
Inst Owner Change1.6%
Ins Owners1.59%
Ins Owner Change0.28%
Market Cap1.56B
Revenue(TTM)214.71M
Net Income(TTM)-2.10M
Analysts83.75
Price Target37.33 (10.09%)
Short Float %6.52%
Short Ratio2.88
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)74.96%
Min EPS beat(2)64.15%
Max EPS beat(2)85.77%
EPS beat(4)3
Avg EPS beat(4)10.46%
Min EPS beat(4)-222.55%
Max EPS beat(4)114.46%
EPS beat(8)7
Avg EPS beat(8)179.5%
EPS beat(12)11
Avg EPS beat(12)144.63%
EPS beat(16)14
Avg EPS beat(16)118.71%
Revenue beat(2)2
Avg Revenue beat(2)4.58%
Min Revenue beat(2)3.69%
Max Revenue beat(2)5.47%
Revenue beat(4)2
Avg Revenue beat(4)1.85%
Min Revenue beat(4)-1.48%
Max Revenue beat(4)5.47%
Revenue beat(8)5
Avg Revenue beat(8)1.84%
Revenue beat(12)7
Avg Revenue beat(12)0.83%
Revenue beat(16)8
Avg Revenue beat(16)0.37%
PT rev (1m)0.55%
PT rev (3m)47.05%
EPS NQ rev (1m)9.63%
EPS NQ rev (3m)-7.66%
EPS NY rev (1m)1.77%
EPS NY rev (3m)0.58%
Revenue NQ rev (1m)1.3%
Revenue NQ rev (3m)1.11%
Revenue NY rev (1m)0.31%
Revenue NY rev (3m)0.33%
Valuation
Industry RankSector Rank
PE 116.93
Fwd PE 68.85
P/S 7.28
P/FCF 759.19
P/OCF 240.27
P/B 12.95
P/tB 13.67
EV/EBITDA 161.15
EPS(TTM)0.29
EY0.86%
EPS(NY)0.49
Fwd EY1.45%
FCF(TTM)0.04
FCFY0.13%
OCF(TTM)0.14
OCFY0.42%
SpS4.66
BVpS2.62
TBVpS2.48
PEG (NY)0.89
PEG (5Y)N/A
Graham Number4.13
Profitability
Industry RankSector Rank
ROA -0.97%
ROE -1.74%
ROCE 2.09%
ROIC 1.65%
ROICexc 2.04%
ROICexgc 2.13%
OM 1.84%
PM (TTM) N/A
GM 74.76%
FCFM 0.96%
ROA(3y)-10.24%
ROA(5y)-11.1%
ROE(3y)-20.3%
ROE(5y)-20.84%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-1.72%
GM growth 5Y-1.5%
F-Score6
Asset Turnover0.99
Health
Industry RankSector Rank
Debt/Equity 0.4
Debt/FCF 23.4
Debt/EBITDA 4.82
Cap/Depr 73.42%
Cap/Sales 2.07%
Interest Coverage 0.59
Cash Conversion 65.09%
Profit Quality N/A
Current Ratio 4.09
Quick Ratio 2.64
Altman-Z 9.74
F-Score6
WACC9.98%
ROIC/WACC0.17
Cap/Depr(3y)361.61%
Cap/Depr(5y)683.78%
Cap/Sales(3y)9.04%
Cap/Sales(5y)13.91%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)2089670227099910400%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%71.43%
EPS Next Y132.02%
EPS Next 2Y94.64%
EPS Next 3Y82.58%
EPS Next 5Y58.75%
Revenue 1Y (TTM)18.72%
Revenue growth 3Y13.72%
Revenue growth 5Y11.92%
Sales Q2Q%23.51%
Revenue Next Year20.14%
Revenue Next 2Y17.85%
Revenue Next 3Y17.64%
Revenue Next 5Y17.07%
EBIT growth 1Y146.36%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year1601.87%
EBIT Next 3Y219.09%
EBIT Next 5Y118.11%
FCF growth 1Y108.56%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y256.84%
OCF growth 3YN/A
OCF growth 5YN/A

AXOGEN INC / AXGN FAQ

What is the fundamental rating for AXGN stock?

ChartMill assigns a fundamental rating of 5 / 10 to AXGN.


What is the valuation status for AXGN stock?

ChartMill assigns a valuation rating of 4 / 10 to AXOGEN INC (AXGN). This can be considered as Fairly Valued.


What is the profitability of AXGN stock?

AXOGEN INC (AXGN) has a profitability rating of 4 / 10.


How financially healthy is AXOGEN INC?

The financial health rating of AXOGEN INC (AXGN) is 6 / 10.


What is the expected EPS growth for AXOGEN INC (AXGN) stock?

The Earnings per Share (EPS) of AXOGEN INC (AXGN) is expected to grow by 132.02% in the next year.